Related Experiment Video
Updated: May 15, 2026

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
Exploring Passive Permeability Profiles of Cyclic Heptapeptide Chemical Space Uncovers Bioactivity of Mortiamide
Jaru Taechalertpaisarn1,2, Alexander Engstrom1, Maria Sajimon1
1Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, California, USA.
Abstract:
We investigated the passive permeability and cytotoxicity of cyclic heptapeptides based on the mortiamide family of natural products. Of all possible stereoisomeric backbones, the natural product's scaffold was among the two most lipophilic as measured by hydrocarbon-water partition coefficients. Using one-bead-one-compound synthesis, we generated a ∼66,000-member library based on the mortiamide scaffold and identified numerous compounds that showed low micromolar cytotoxicity against synovial sarcoma and breast cancer cell lines. Physicochemical characterization revealed that these compounds, including the known mortiamides, have very low aqueous solubilities and form amyloid-like fibril aggregates. Multiple lines of evidence-including detergent-reversible enzyme inhibition, thioflavin T fluorescence, transmission electron microscopy, and equipotent enantiomeric pairs-demonstrate that the observed bioactivity arises from colloidal aggregation rather than specific target engagement. Our findings highlight the critical importance of early physicochemical evaluation in natural product-inspired drug discovery and underscore how aggregation-prone scaffolds can generate misleading structure-activity relationships.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025